Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability of QUTENZATM When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study

NCT01416116 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01416116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01416116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability of QUTENZATM When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
July 6, 2011
Completion date
April 25, 2012
Enrollment
122 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

or peripheral nerve injury (pni), peripheral neuropathic pain (pnp) due to postherpetic neuralgia (phn)